—
Enter label dose
Trial reference
From your label
Enter your label dose — the gauge updates instantly.
1000 mg/day for 6 weeks in a randomized double-blind crossover trial in healthy middle-aged and older adults; well-tolerated, elevated whole-blood NAD+. Cited in our urolithin A vs NMN guide, which covers the NAD+ booster shelf context.
Educational only — not medical advice. Disclaimer.
NIH DSLD market slice
Bulk CSV dump 16 January 2026 · label entries through 2025. Disclosed amounts only — proprietary blends without gram weights excluded.
Trial floors
Primary
NAD+ elevation trial (1000 mg/day) · 1,000 mg over 6 weeks · Secondary outcomes only — 1000 mg/day for 6 weeks in a randomized double-blind crossover trial in healthy middle-aged and older adults; well-tolerated, elevated whole-blood NAD+. Cited in our urolithin A vs NMN guide, which covers the NAD+ booster shelf context.
Label reading notes
- Labels list NR in mg. Trials used 1000 mg/day of the chloride salt; shelf doses range from 250 to 500 mg per serving, below the studied floor.